1. An M, Toochinda T, Bartlett PA (2001) Five-membered ring analogues of shikimic acid. J Org Chem 66(4):1326–1333
2. Bandodkar BS, Schmitt S (2007) Pyrazolone derivatives for treatment of tuberculosis. Patent: WO 2007/020426 A1
3. Bandodkar B, Naik M, Ghorpade S, Kale M, Shanbhag G, Patil V, Solapure S, Balganesh M, Shandil R, Balasubramanian V, Vachaspati P, Kothandaraman S, Panda M, Raichurkar A, Venkatraman J, Paul B, Sheik G, Subbulakshmi V, Ramachandran V, Kaur P, Ravishankar R, Barde S, Giridhar J, Arora U, Reddy J, Gaonkar S, Bharath S, Kumar N, Jayaram R, Datta S, Schmitt S (2009) In: Abstracts of Forty-ninth Interscience Conference on Antimicrob Agents and Chemother, San Francisco, 2009. In: Lead generation via virtual screening: discovery of pyrazolones as potent antimycobacterial leads through structure based virtual screening of shikimate kinase. Abstract F2017. American Society for Microbiology, Washington, DC, 2009
4. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242
5. Blanco B, Prado V, Lence E, Otero JM, Garcia-Doval C, van Raaij M, Llamas-Saiz AL, Lamb H, Hawkins AR, González-Bello C (2013) Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover. Jacs 135(33):12366–12376